Dmitry Balyasny’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-25,000
Closed -$1.9M 2796
2022
Q1
$1.9M Buy
+25,000
New +$1.98M 0.01% 1403
2021
Q4
Sell
-10,000
Closed -$756K 2281
2021
Q3
$756K Buy
+10,000
New +$794K ﹤0.01% 1395
2021
Q2
Sell
-100,000
Closed -$7.88M 2008
2021
Q1
$7.88M Buy
+100,000
New +$7.84M 0.04% 555
2017
Q4
Sell
-100,000
Closed -$7.29M 2080
2017
Q3
$7.29M Hold
100,000
0.03% 597
2017
Q2
$7.41M Buy
+100,000
New +$7.42M 0.03% 635
2013
Q4
Sell
-100,000
Closed -$935K 507
2013
Q3
$935K Buy
+100,000
New +$5.92M 0.01% 530

Other funds holding CL

Dmitry Balyasny's CL Position: Q2 2026 in Review

Dmitry Balyasny increased its Colgate-Palmolive (CL) stake by 3,907% in Q2 2026, buying an estimated $64M and bringing the position to 749,667 shares worth $68.7M. The position accounts for 0.09% of the portfolio, ranked #276.

Dmitry Balyasny first reported a position in CL in Q3 2013 and has held it in 30 quarters since. The position peaked at $237M in Q4 2025. 2,007 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Dmitry Balyasny held 749,667 shares of Colgate-Palmolive worth $68.7M as of Q2 2026.
  • Dmitry Balyasny bought 730,960 Colgate-Palmolive shares in Q2 2026, an estimated $64M.
  • Colgate-Palmolive made up 0.09% of Dmitry Balyasny's portfolio in Q2 2026, its #276 holding.
  • Dmitry Balyasny first reported a position in Colgate-Palmolive in Q3 2013 and has held it in 30 quarters since.
  • Dmitry Balyasny's Colgate-Palmolive position peaked at $237M in Q4 2025.
  • 2,007 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.